CTT Pharmaceutical (CTTH) CEO buys 10,000 more shares
Rhea-AI Filing Summary
CTT Pharmaceutical Holdings, Inc. (CTTH) reported an insider purchase of its common stock. The reporting person, listed as CTT Pharmaceutical Holdings, Inc. in its capacity as CEO, purchased 10,000 CTTH shares on 2026-08-19 at $0.059 per share in an open-market or private transaction. Following this transaction, the filing reports 9,365,456 shares of CTTH common stock held with direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
CTT PHARMACEUTICAL HOLDINGS, INC.
Role
CEO
Bought
10,000 shs ($590.00)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | CTTH | 10,000 | $0.059 | $590.00 |
Holdings After Transaction:
CTTH — 9,365,456 shares (Direct)
Key Figures
Shares purchased: 10,000 shares
Purchase price: $0.059 per share
Shares owned after transaction: 9,365,456 shares
+1 more
4 metrics
Shares purchased
10,000 shares
Non-derivative common stock transaction on 2026-08-19
Purchase price
$0.059 per share
Price for the 10,000-share purchase on 2026-08-19
Shares owned after transaction
9,365,456 shares
Direct ownership position reported following the purchase
Net buy shares in filing
10,000 shares
Net buy direction based on transactionSummary
Key Terms
Form 4, beneficial ownership, Rule 10b5-1
3 terms
Form 4 regulatory
"This Form 4 reports an insider purchase of CTTH common stock"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
beneficial ownership financial
"The filing reflects beneficial ownership of 9,365,456 shares after the trade"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Rule 10b5-1 regulatory
"The Rule 10b5-1 checkbox is not marked for this transaction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did CTTH report on this Form 4?
CTTH reported an insider purchase of 10,000 shares of its common stock on 2026-08-19 at a price of $0.059 per share. The transaction is classified as a purchase in an open-market or private transaction.
Was the CTTH insider trade made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and there are no footnotes stating the trade was made pursuant to a pre-arranged trading plan, so the transaction is not identified as 10b5-1.
Is this CTTH Form 4 transaction a buy or a sell?
The transaction is a buy. The Form 4 uses transaction code P and an acquired/disposed code of A, which the structured data classifies as a purchase, with 10,000 shares bought.
AI-generated analysis. How Rhea-AI works. Not financial advice.
